The shotgun proteomic study of the human ThinPrep cervical smear using iTRAQ mass-tagging and 2D LC-FT-Orbitrap-MS: The detection of the human papillomavirus at the protein level

Journal of Proteome Research

Volumn 12, Issue 5, 2013, Pages 2078-2089

  Papachristou, Evaggelia K ^a,d   Roumeliotis, Theodoros I ^a   Chrysagi, Argyro ^b   Trigoni, Chrysanthi ^b   Charvalos, Ekatherina ^b   Townsend, Paul A ^e   Pavlakis, Kitty ^c   Garbis, Spiros D ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b IASO   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

cervical cancer; cervical smear; CID; HCD; HPV; iTRAQ; Orbitrap Elite; phosphorylation; power analysis; proteomics; sample size; ThinPrep

Indexed keywords

ARTICLE; COLLISIONALLY ACTIVATED DISSOCIATION; DNA HYBRIDIZATION; HUMAN PAPILLOMAVIRUS TYPE 16; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

AMINO ACID SEQUENCE; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; ISOTOPE LABELING; MOLECULAR SEQUENCE ANNOTATION; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRUS INFECTIONS; PROTEOME; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIRAL PROTEINS;

EID: 84877157474     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr301067r     Document Type: Article

References (51)

1. Cox, J.; Mann, M. Quantitative, high-resolution proteomics for data-driven systems biology Annu. Rev. Biochem. 2011, 80, 273-99
2. Bouchal, P.; Roumeliotis, T.; Hrstka, R.; Nenutil, R.; Vojtesek, B.; Garbis, S. D. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis J. Proteome Res. 2009, 8 (1) 362-73
3. Garbis, S. D.; Tyritzis, S. I.; Roumeliotis, T.; Zerefos, P.; Giannopoulou, E. G.; Vlahou, A.; Kossida, S.; Diaz, J.; Vourekas, S.; Tamvakopoulos, C.; Pavlakis, K.; Sanoudou, D.; Constantinides, C. A. Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry J. Proteome Res. 2008, 7 (8) 3146-58
4. Garbis, S. D.; Roumeliotis, T. I.; Tyritzis, S. I.; Zorpas, K. M.; Pavlakis, K.; Constantinides, C. A. A novel multidimensional protein identification technology approach combining protein size exclusion prefractionation, peptide zwitterion-ion hydrophilic interaction chromatography, and nano-ultraperformance RP chromatography/nESI-MS2 for the in-depth analysis of the serum proteome and phosphoproteome: application to clinical sera derived from humans with benign prostate hyperplasia Anal. Chem. 2011, 83 (3) 708-18
5. Addona, T. A.; Shi, X.; Keshishian, H.; Mani, D. R.; Burgess, M.; Gillette, M. A.; Clauser, K. R.; Shen, D.; Lewis, G. D.; Farrell, L. A.; Fifer, M. A.; Sabatine, M. S.; Gerszten, R. E.; Carr, S. A. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease Nat. Biotechnol. 2011, 29 (7) 635-43
6. Pavlou, M. P.; Kulasingam, V.; Sauter, E. R.; Kliethermes, B.; Diamandis, E. P. Nipple aspirate fluid proteome of healthy females and patients with breast cancer Clin. Chem. 2010, 56 (5) 848-55
7. Nagaraj, N.; Wisniewski, J. R.; Geiger, T.; Cox, J.; Kircher, M.; Kelso, J.; Paabo, S.; Mann, M. Deep proteome and transcriptome mapping of a human cancer cell line Mol. Syst. Biol. 2011, 7, 548
8. Sardana, G.; Marshall, J.; Diamandis, E. P. Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium Clin. Chem. 2007, 53 (3) 429-37
9. Naji, S.; Ambrus, G.; Cimermancic, P.; Reyes, J. R.; Johnson, J. R.; Filbrandt, R.; Huber, M. D.; Vesely, P.; Krogan, N. J.; Yates, J. R., 3rd; Saphire, A. C.; Gerace, L. Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production Mol. Cell. Proteomics 2012, 11 (4) M111 015313
10. Munday, D. C.; Surtees, R.; Emmott, E.; Dove, B. K.; Digard, P.; Barr, J. N.; Whitehouse, A.; Matthews, D.; Hiscox, J. A. Using SILAC and quantitative proteomics to investigate the interactions between viral and host proteomes Proteomics 2012, 12 (4-5) 666-72
11. Dove, B. K.; Surtees, R.; Bean, T. J.; Munday, D.; Wise, H. M.; Digard, P.; Carroll, M. W.; Ajuh, P.; Barr, J. N.; Hiscox, J. A. A quantitative proteomic analysis of lung epithelial (A549) cells infected with 2009 pandemic influenza A virus using stable isotope labelling with amino acids in cell culture Proteomics 2012, 12 (9) 1431-6
12. Feng, X.; Zhang, J.; Chen, W. N.; Ching, C. B. Proteome profiling of Epstein-Barr virus infected nasopharyngeal carcinoma cell line: identification of potential biomarkers by comparative iTRAQ-coupled 2D LC/MS-MS analysis J. Proteomics 2011, 74 (4) 567-76
13. Munday, D. C.; Emmott, E.; Surtees, R.; Lardeau, C. H.; Wu, W.; Duprex, W. P.; Dove, B. K.; Barr, J. N.; Hiscox, J. A. Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus Mol. Cell. Proteomics 2010, 9 (11) 2438-59
14. Moore, P. S.; Chang, Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology Nat. Rev. Cancer 2010, 10 (12) 878-89
15. Butt, A. Q.; Miggin, S. M. Cancer and viruses: A double-edged sword Proteomics 2012, 12 (13) 2127-38
16. zur Hausen, H. Papillomaviruses and cancer: from basic studies to clinical application Nat. Rev. Cancer 2002, 2 (5) 342-50
17. Crow, J. M. HPV: The global burden Nature 2012, 488 (7413) S2-3
18. Martin, D.; Gutkind, J. S. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer Oncogene 2008, 27 (Suppl 2) S31-42
19. Alameda, F.; Marinoso, M. L.; Bellosillo, B.; Muset, M.; Pairet, S.; Soler, I.; Romero, E.; Larrazabal, F.; Carreras, R.; Serrano, S. Detection of HPV by in situ hybridization in thin-layer (ThinPrep) cervicovaginal samples Tumor Biol. 2011, 32 (3) 603-9
20. Bai, H.; Sung, C. J.; Steinhoff, M. M. ThinPrep Pap Test promotes detection of glandular lesions of the endocervix Diagn. Cytopathol. 2000, 23 (1) 19-22
21. Khan, M. J.; Castle, P. E.; Lorincz, A. T.; Wacholder, S.; Sherman, M.; Scott, D. R.; Rush, B. B.; Glass, A. G.; Schiffman, M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice JNCI, J. Natl. Cancer Inst. 2005, 97 (14) 1072-9
22. Schorge, J. O.; Hossein Saboorian, M.; Hynan, L.; Ashfaq, R. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study Cancer 2002, 96 (6) 338-43
23. Whitlock, E. P.; Vesco, K. K.; Eder, M.; Lin, J. S.; Senger, C. A.; Burda, B. U. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force Ann. Intern. Med. 2011, 155 (10) 687-97; W214-5
24. Burd, E. M. Human papillomavirus and cervical cancer Clin. Microbiol. Rev. 2003, 16 (1) 1-17
25. Swan, D. C.; Tucker, R. A.; Tortolero-Luna, G.; Mitchell, M. F.; Wideroff, L.; Unger, E. R.; Nisenbaum, R. A.; Reeves, W. C.; Icenogle, J. P. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type J. Clin. Microbiol. 1999, 37 (4) 1030-4
26. Alazawi, W.; Pett, M.; Arch, B.; Scott, L.; Freeman, T.; Stanley, M. A.; Coleman, N. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16 Cancer Res. 2002, 62 (23) 6959-65
27. Rader, J. S.; Malone, J. P.; Gross, J.; Gilmore, P.; Brooks, R. A.; Nguyen, L.; Crimmins, D. L.; Feng, S.; Wright, J. D.; Taylor, N.; Zighelboim, I.; Funk, M. C.; Huettner, P. C.; Ladenson, J. H.; Gius, D.; Townsend, R. R. A unified sample preparation protocol for proteomic and genomic profiling of cervical swabs to identify biomarkers for cervical cancer screening Proteomics: Clin. Appl. 2008, 2 (12) 1658-69
28. Gu, Y.; Wu, S. L.; Meyer, J. L.; Hancock, W. S.; Burg, L. J.; Linder, J.; Hanlon, D. W.; Karger, B. L. Proteomic analysis of high-grade dysplastic cervical cells obtained from ThinPrep slides using laser capture microdissection and mass spectrometry J. Proteome Res. 2007, 6 (11) 4256-68
29. Unwin, R. D.; Griffiths, J. R.; Whetton, A. D. Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS/MS Nat. Protoc. 2010, 5 (9) 1574-82
30. Levin, Y. The role of statistical power analysis in quantitative proteomics Proteomics 2011, 11 (12) 2565-7
31. Zhou, C.; Simpson, K. L.; Lancashire, L. J.; Walker, M. J.; Dawson, M. J.; Unwin, R. D.; Rembielak, A.; Price, P.; West, C.; Dive, C.; Whetton, A. D. Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery J. Proteome Res. 2012, 11 (4) 2103-13
32. Vizcaino, J. A.; Cote, R.; Reisinger, F.; Barsnes, H.; Foster, J. M.; Rameseder, J.; Hermjakob, H.; Martens, L. The Proteomics Identifications database: 2010 update Nucleic Acids Res. 2010, 38 (Database issue) D736-42
33. Davies, P.; Kornegay, J.; Iftner, T. Current methods of testing for human papillomavirus. Best practice & research Clin. Obstet. Gynecol. 2001, 15 (5) 677-700
34. Gravitt, P. E.; Peyton, C. L.; Alessi, T. Q.; Wheeler, C. M.; Coutlee, F.; Hildesheim, A.; Schiffman, M. H.; Scott, D. R.; Apple, R. J. Improved amplification of genital human papillomaviruses J. Clin. Microbiol. 2000, 38 (1) 357-61
35. Gilar, M.; Olivova, P.; Daly, A. E.; Gebler, J. C. Orthogonality of separation in two-dimensional liquid chromatography Anal. Chem. 2005, 77 (19) 6426-34
36. Kil, Y. J.; Becker, C.; Sandoval, W.; Goldberg, D.; Bern, M. Preview: a program for surveying shotgun proteomics tandem mass spectrometry data Anal. Chem. 2011, 83 (13) 5259-67
37. Boersema, P. J.; Raijmakers, R.; Lemeer, S.; Mohammed, S.; Heck, A. J. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics Nat. Protoc. 2009, 4 (4) 484-94
38. Gyongyosi, E.; Szalmas, A.; Ferenczi, A.; Konya, J.; Gergely, L.; Veress, G. Effects of human papillomavirus (HPV) type 16 oncoproteins on the expression of involucrin in human keratinocytes Virol. J. 2012, 9, 36
39. Longworth, M. S.; Laimins, L. A. Pathogenesis of human papillomaviruses in differentiating epithelia Microbiol. Mol. Biol. Rev. 2004, 68 (2) 362-72
40. Biet, F.; Locht, C.; Kremer, L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens J. Mol. Med. 2002, 80 (3) 147-62
41. Cho, Y. S.; Kang, J. W.; Cho, M.; Cho, C. W.; Lee, S.; Choe, Y. K.; Kim, Y.; Choi, I.; Park, S. N.; Kim, S.; Dinarello, C. A.; Yoon, D. Y. Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18 FEBS Lett. 2001, 501 (2-3) 139-45
42. Syrjanen, S.; Naud, P.; Sarian, L.; Derchain, S.; Roteli-Martins, C.; Longatto-Filho, A.; Tatti, S.; Branca, M.; Erzen, M.; Hammes, L. S.; Costa, S.; Syrjanen, K. Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort Virchows Arch. 2009, 455 (6) 505-15
43. Shaw, J. L.; Smith, C. R.; Diamandis, E. P. Proteomic analysis of human cervico-vaginal fluid J. Proteome Res. 2007, 6 (7) 2859-65
44. Dasari, S.; Pereira, L.; Reddy, A. P.; Michaels, J. E.; Lu, X.; Jacob, T.; Thomas, A.; Rodland, M.; Roberts, C. T., Jr.; Gravett, M. G.; Nagalla, S. R. Comprehensive proteomic analysis of human cervical-vaginal fluid J. Proteome Res. 2007, 6 (4) 1258-68
45. Obiezu, C. V.; Diamandis, E. P. Human tissue kallikrein gene family: applications in cancer Cancer Lett. 2005, 224 (1) 1-22
46. Zerbini, M.; Venturoli, S.; Cricca, M.; Gallinella, G.; De Simone, P.; Costa, S.; Santini, D.; Musiani, M. Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA J. Clin. Pathol. 2001, 54 (5) 377-80
47. Massimi, P.; Banks, L. Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle Virology 2000, 276 (2) 388-94
48. Massimi, P.; Pim, D.; Kuhne, C.; Banks, L. Regulation of the human papillomavirus oncoproteins by differential phosphorylation Mol. Cell. Biochem. 2001, 227 (1-2) 137-44
49. Grand, R. J.; Doorbar, J.; Smith, K. J.; Coneron, I.; Gallimore, P. H. Phosphorylation of the human papillomavirus type 1 E4 proteins in vivo and in vitro Virology 1989, 170 (1) 201-13
50. Nilsson, C. L. Advances in quantitative phosphoproteomics Anal. Chem. 2012, 84 (2) 735-46
51. Evans, V. C.; Barker, G.; Heesom, K. J.; Fan, J.; Bessant, C.; Matthews, D. A. De novo derivation of proteomes from transcriptomes for transcript and protein identification Nat. Methods 2012, 9 (12) 1207-11